Advancements in Antiepileptic Drugs (AEDs)

Advancements in antiepileptic drugs (AEDs) represent a significant leap in the management of epilepsy, offering new hope for individuals with seizures that are difficult to control. Modern AEDs, developed with improved pharmacological profiles, are designed to target specific neurotransmitter systems or ion channels involved in seizure generation, leading to enhanced efficacy and reduced side effects compared to older medications. For instance, drugs like levetiracetam and lamotrigine have become popular due to their favorable side effect profiles and broad-spectrum efficacy. Additionally, the development of novel AEDs such as cannabidiol, derived from cannabis, has shown promise in treating drug-resistant epilepsy, particularly in syndromes like Dravet and Lennox-Gastaut. The ongoing research into personalized medicine aims to tailor AED therapy based on individual genetic and metabolic profiles, optimizing treatment outcomes and minimizing adverse effects. This advancement also includes the refinement of drug delivery systems, such as extended-release formulations, which provide more stable blood levels of the medication and improve adherence. However, challenges remain, including the high cost of new drugs and the need for continued research into their long-term safety and effectiveness

    Related Conference of Advancements in Antiepileptic Drugs (AEDs)

    July 20-21, 2026

    37th World Congress on Neurology and Neuroscience

    Amsterdam, Netherlands
    July 20-21, 2026

    11th International Conference on Central Nervous System Disorders & Therapeutics

    Amsterdam, Netherlands
    July 23-24, 2026

    14th International Conference on Cannabis & Medicinal Research

    Amsterdam, Netherlands
    August 24-25, 2026

    15th International Conference on Brain Disorders and Therapeutics

    London, UK
    August 27-28, 2026

    35th Euro Congress on Neurologists and Psychiatrists

    ,
    September 17-18, 2026

    31st Global Experts Meeting on Neuroscience and Neuropharmacology

    Paris, France
    September 18-19, 2026

    21st Annual Congress on Neuroscience

    Dubai, UAE
    October 15-16, 2026

    32nd International conference on Neurosurgery and Brain Disorders

    Madrid, Spain
    October 19-20, 2026

    39th International Conference on Neuroscience and Neurochemistry

    Paris, France
    November 16-17, 2026

    14th International Conference on Nephrology and Kidney Diseases

    Paris, France
    November 16-17, 2026

    8th World Brain Congress

    Tokyo, Japan
    November 23-24, 2026

    16th Global Alzheimers Summit

    Paris, France
    November 24-25, 2026

    38th World Conference on Neurology

    Rome, Italy
    December 15-16, 2026

    12th International Conference on Spine and Spinal Disorders

    Paris, France
    December 21-22, 2026

    6th International Conference on Child Neurology

    Paris, France
    December 28-29, 2026

    39th European Neurology Congress

    Amsterdam, Netherlands
    December 28-29, 2026

    18th Global Neurologists Meeting on Neurology and Neurosurgery

    Amsterdam, Netherlands
    March 22-23, 2027

    8th International Conference on Neurologists

    Singapore City, Singapore
    March 22-23, 2027

    8th World Congress on Sleep Disorders and Therapeutics

    Paris, France
    March 25-26, 2027

    39th International conference on Mental Health and Psychiatry

    Paris, France
    March 30-31, 2027

    31st International Conference on Neurology & Neurophysiology

    London, UK
    April 27-28, 2027

    18th International Conference on Stroke, Neurology and Cerebrovascular Diseases

    Paris, France
    May 20-21, 2027

    10th International Conference on Neurology and Psychology

    Paris, France
    May 27-28, 2027

    8th International Summit on Mental Disorders and Illness

    Paris, France

    Advancements in Antiepileptic Drugs (AEDs) Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in